Download Zipped Enrolled WordPerfect HB0017.ZIP
[Introduced][Amended][Status][Bill Documents][Fiscal Note][Bills Directory]

H.B. 17 Enrolled





Chief Sponsor: Jennifer M. Seelig

Senate Sponsor: Stephen H. Urquhart

             6      Cosponsors:
             7      Sheryl L. Allen
             8      Jackie Biskupski
             9      Rebecca Chavez-Houck
             10      Julie FisherLorie D. Fowlke
Neil A. Hansen
Neal B. Hendrickson
Christine A. Johnson
David LitvackPaul Ray
Phil Riesen
Evan J. Vickers
Larry B. Wiley              11     
             12      LONG TITLE
             13      General Description:
             14          This bill amends the Pharmacy Practice Act in the Division of Occupational and
             15      Professional Licensing Act.
             16      Highlighted Provisions:
             17          This bill:
             18          .    defines terms;
             19          .    excludes from the definition of unprofessional conduct and unlawful conduct under
             20      the Division of Occupational and Professional Licensing, issuing a prescription for
             21      an antibiotic to an unnamed partner of a person who has any one of certain
             22      designated sexually transmitted diseases;
             23          .    does not mandate the use of expedited partner therapy;
             24          .    provides an option for a practitioner to use expedited partner therapy;
             25          .    makes conforming changes to the Pharmacy Practices Act;
             26          .    provides immunity from medical malpractice actions for a practitioner who uses
             27      expedited partner therapy; and
             28          .    makes technical changes.
             29      Monies Appropriated in this Bill:
             30          None

             31      Other Special Clauses:
             32          None
             33      Utah Code Sections Affected:
             34      AMENDS:
             35          58-17b-602, as last amended by Laws of Utah 2007, Chapter 279
             36      ENACTS:
             37          58-1-501.3, Utah Code Annotated 1953
             39      Be it enacted by the Legislature of the state of Utah:
             40          Section 1. Section 58-1-501.3 is enacted to read:
             41          58-1-501.3. Health professional prescribing exceptions for expedited partner
             42      therapy for sexually transmitted diseases.
             43          (1) For purposes of this section:
             44          (a) "Drug to treat a sexually transmitted disease" means a drug:
             45          (i) as defined in Section 58-17b-102 ; and
             46          (ii) that is:
             47          (A) an antibiotic; and
             48          (B) prescribed in accordance with guidelines from the Centers for Disease Control and
             49      Prevention for patient delivered expedited partner therapy in the management of sexually
             50      transmitted disease.
             51          (b) "Partner" means a person:
             52          (i) with whom a practitioner does not have a bonafide practitioner-patient relationship;
             53      and
             54          (ii) who is identified as, or claims to be a sexual partner of a patient.
             55          (c) "Patient" means a person who:
             56          (i) has a sexually transmitted disease; and
             57          (ii) has a bonafide practitioner-patient relationship with a practitioner.
             58          (d) "Sexually transmitted disease" means:

             59          (i) gonorrhea; or
             60          (ii) chlamydia.
             61          (2) This section does not require a practitioner or a licensee under this chapter to
             62      prescribe or dispense a drug to treat a sexually transmitted disease for patient delivered
             63      expedited partner therapy. A practitioner's or licensee's decision to use expedited partner
             64      therapy as allowed by this section is voluntary.
             65          (3) Notwithstanding Sections 58-1-501 , 58-17b-501 , and 58-17b-502 , it is not
             66      unlawful conduct or unprofessional conduct, and it does not violate the provisions of this
             67      chapter if:
             68          (a) a practitioner, in accordance with this Subsection (3):
             69          (i) issues a prescription for a drug to treat a sexually transmitted disease to a partner
             70      by:
             71          (A) writing "partner of (patient name)" on the prescription order; and
             72          (B) giving the partner's prescription to the patient for subsequent use by the partner; or
             73          (ii) notwithstanding Section 58-17b-610 , dispenses a drug sample to treat a sexually
             74      transmitted disease to the patient for the subsequent use of the partner; or
             75          (b) a pharmacist, in accordance with this Subsection (3), dispenses a prescription drug
             76      for the treatment of a sexually transmitted disease to:
             77          (i) a person who:
             78          (A) claims to be a partner; and
             79          (B) presents a prescription for the drug to the pharmacist which is written for the
             80      unnamed partner of a named patient;
             81          (ii) the patient for the subsequent use by the unnamed partner; or
             82          (iii) an agent of the patient or partner.
             83          (4) (a) For purposes of Subsection (3), and notwithstanding Section 58-17b-602 :
             84          (i) the partner does not have to be identified on the prescription order by information
             85      that would disclose the identity of the partner; and
             86          (ii) when dispensing a drug to treat a sexually transmitted disease directly to the

             87      partner, the patient's identifying information may, but does not need to, be included on the
             88      partner's drug label.
             89          (b) Information provided by a pharmacist to a patient or the patient's agent for
             90      subsequent use by a partner satisfies the requirements of patient counseling for both the
             91      patient and the partner under Section 58-17b-613 .
             92          (5) (a) The Legislature finds that the prevention and treatment of sexually transmitted
             93      diseases in the state is a compelling public health issue.
             94          (b) A practitioner or licensee under this chapter is not liable for a medical malpractice
             95      action if the use of expedited partner therapy is in compliance with this section, except for
             96      those acts which are grossly negligent or willful and wanton.
             97          Section 2. Section 58-17b-602 is amended to read:
             98           58-17b-602. Prescription orders -- Information required -- Alteration -- Labels --
             99      Signatures -- Dispensing in pharmacies.
             100          (1) [The] Except as provided in Section 58-1-501.3 , the minimum information that
             101      shall be included in a prescription order, and that may be defined by rule, is:
             102          (a) the prescriber's name, address, and telephone number, and, if the order is for a
             103      controlled substance, the patient's age and the prescriber's DEA number;
             104          (b) the patient's name and address or, in the case of an animal, the name of the owner
             105      and species of the animal;
             106          (c) the date of issuance;
             107          (d) the name of the medication or device prescribed and dispensing instructions, if
             108      necessary;
             109          (e) the directions, if appropriate, for the use of the prescription by the patient or
             110      animal and any refill, special labeling, or other instructions;
             111          (f) the prescriber's signature if the prescription order is written;
             112          (g) if the order is an electronically transmitted prescription order, the prescribing
             113      practitioner's electronic signature; and
             114          (h) if the order is a hard copy prescription order generated from electronic media, the

             115      prescribing practitioner's electronic or manual signature.
             116          (2) The requirement of Subsection (1)(a) does not apply to prescription orders
             117      dispensed for inpatients by hospital pharmacies if the prescriber is a current member of the
             118      hospital staff and the prescription order is on file in the patient's medical record.
             119          (3) Unless it is for a Schedule II controlled substance, a prescription order may be
             120      dispensed by [pharmacists] a pharmacist or pharmacy [interns] intern upon an oral
             121      prescription of a practitioner only if the oral prescription is promptly reduced to writing.
             122          (4) (a) Except as provided under Subsection (4)(b), a pharmacist or pharmacy intern
             123      may not dispense or compound any prescription of a practitioner if [it] the prescription shows
             124      evidence of alteration, erasure, or addition by any person other than the person writing the
             125      prescription.
             126          (b) A pharmacist or pharmacy intern dispensing or compounding a prescription may
             127      alter or make additions to the prescription after receiving permission of the prescriber and may
             128      make entries or additions on the prescription required by law or necessitated in the
             129      compounding and dispensing procedures.
             130          (5) Each drug dispensed shall have a label securely affixed to the container indicating
             131      the following minimum information:
             132          (a) the name, address, and telephone number of the pharmacy;
             133          (b) the serial number of the prescription as assigned by the dispensing pharmacy;
             134          (c) the filling date of the prescription or its last dispensing date;
             135          (d) the name of the patient, or in the case of an animal, the name of the owner and
             136      species of the animal;
             137          (e) the name of the prescriber;
             138          (f) the directions for use and cautionary statements, if any, which are contained in the
             139      prescription order or are needed;
             140          (g) except as provided in Subsection (6), the trade, generic, or chemical name, amount
             141      dispensed and the strength of dosage form, but if multiple ingredient products with established
             142      proprietary or nonproprietary names are prescribed, those products' names may be used; and

             143          (h) the beyond use date.
             144          (6) If the prescriber specifically indicates the name of the prescription product should
             145      not appear on the label, then any of the trade, generic, chemical, established proprietary, and
             146      established nonproprietary names and the strength of dosage form may not be included.
             147          (7) Except when it is delivered to the ultimate user via the United States Postal
             148      Service, licensed common carrier, or supportive personnel, a prescription drug may be
             149      dispensed to the ultimate user or his agent only at a licensed pharmacy.

[Bill Documents][Bills Directory]